Guolian MinSheng Securities Underwriting and Sponsorship Co., Ltd. Regarding Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s Audit Opinion on the Storage, Management, and Use of Raised Funds for 2025
In accordance with the "Administrative Measures for the Sponsorship Business of Securities Issuance and Listing" issued by the China Securities Regulatory Commission, the "Supervision Rules for Listed Companies' Raised Funds," the "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guide No. 1 - Normative Operation of Main Board Listed Companies," and the "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guide No. 13 - Sponsorship Business," etc., Guolian MinSheng Securities Underwriting and Sponsorship Co., Ltd. (hereinafter referred to as "Guolian MinSheng Underwriting and Sponsorship" or "Sponsor"), as the continuing supervision institution for Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (hereinafter referred to as "Mindray" or "the Company"), has audited the storage, management, and use of Mindray's raised funds for 2025. The specific situation is as follows:
I. Guolian MinSheng Underwriting and Sponsorship's Audit Work
Guolian MinSheng Underwriting and Sponsorship reviewed the Company's Board of Directors' special report on the annual storage, management, and use of raised funds, the audit report on the storage, management, and actual use of raised funds issued by Daixin Certified Public Accountants (Special General Partnership), examined the detailed ledger of fund usage in the raised fund accounts, obtained the bank statements for the raised fund special accounts from the banks where the accounts are located, and communicated with the Company's financial director, secretary of the board, and other personnel to audit the use of raised funds and project progress.